Related Experiment Video
Updated: Jul 10, 2026
16:36
Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
Molecular Hybridization of Clinically Relevant P2X7 Antagonists
Nicholas B Lynch1, Charleigh T A Agius2, André D J McKenzie1
1School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia.
Chemmedchem
|July 8, 2026
Summary
Researchers explored new drug candidates for neurodegenerative diseases by combining existing P2X7 receptor antagonists. This molecular hybridization approach yielded a library of novel compounds for further development.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- The P2X7 receptor is implicated in neurodegenerative diseases.
- Current therapies targeting P2X7 receptors are limited, with none on the market.
- Existing antagonists include AZD-9056 and JNJ-54175446.
Purpose of the Study:
- To discover novel P2X7 receptor antagonists.
- To explore new chemical space around clinically validated P2X7 antagonists.
- To demonstrate the utility of molecular hybridization in drug discovery.
Main Methods:
- Utilized a molecular hybridization strategy.
- Synthesized a library of 22 novel compounds.
- Conducted in vitro and in silico evaluations of the synthesized compounds.
Main Results:
- Successfully synthesized and evaluated 22 new compounds.
- Explored novel chemical structures based on AZD-9056 and JNJ-54175446.
- Identified promising candidates for P2X7 receptor antagonist development.
Conclusions:
- Molecular hybridization is a valuable strategy for drug discovery.
- The developed compound library provides a foundation for future P2X7 antagonist research.
- Further development of these compounds may lead to new therapies for neurodegenerative diseases.
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.